MRNA Stock Score & AI Analysis
AI-scored September 15, 2026 · 15-dimension engine · 30+ data sources
MRNA scores 12/100 — SELL. Strongest on earnings quality, weakest on fundamentals.
Why MRNA scores 12
- MACD bearish crossover
- Price above key moving averages
- PEG undervalued (-2.76)
Strongest dimension: earnings quality · Weakest: fundamentals
MRNA balance sheet
NET CASHCan this company fund itself without the capital markets? Straight from the quarterly filings.
As of the June 30, 2026 balance sheet.
See the full 15-dimension breakdown for MRNA
Every component score, the full research report, trade plan, options flow, insider & congressional activity — updated every morning before the bell.
Start Free Trial →MRNA — frequently asked
Our AI engine currently rates MRNA SELL, with a composite score of 12/100 across 15 dimensions. This is software-generated analysis, not personalized investment advice.
MRNA scores 12 out of 100 — lower than 88% of the stocks we screen. The score blends technicals, fundamentals, sentiment, momentum, smart-money flow, options flow, earnings, and insider activity.
Wall Street Analyst reads 30+ live data sources every morning and scores MRNA on a 15-dimension engine. The full per-dimension breakdown and research report are available to members.
Wall Street Analyst is financial software and education — not personalized investment advice, and we are not a registered investment advisor. Scores are model-generated and update daily. Markets carry risk; past results don't guarantee future ones, and every decision is yours.